STOCK TITAN

Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference

Bio-Techne (NASDAQ: TECH) said Kim Kelderman, President and CEO, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026 at 9:20 a.m. PDT.

(Neutral)
(Neutral)
Tags

Bio-Techne (NASDAQ: TECH) said Kim Kelderman, President and CEO, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026 at 9:20 a.m. PDT. A live webcast will be available via the company’s investor relations IR Calendar page.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus May 4 session
-0.51% close to close Open Argus
Details

News Market Reaction – TECH

On May 4, the day this news came out, TECH closed 0.51% below the previous close.

Data tracked by StockTitan Argus for the May 4 session.

Market Context

This announcement adds another investor-focused event to Bio-Techne’s calendar, with management pres...
Analysis

This announcement adds another investor-focused event to Bio-Techne’s calendar, with management presenting at a major healthcare conference on May 12, 2026. Recent history features mixed market reactions to branding, product, and regulatory milestones, as well as prior conferences. Shares had been trading below the 200-day MA before this news, and insider activity over the past 90 days showed net selling. Investors may watch upcoming earnings, product updates, and additional conferences for clearer directional signals.

Key Figures

Conference time: 9:20 a.m. PDT
Conference time
9:20 a.m. PDT
Bank of America Securities 2026 Global Healthcare Conference presentation on May 12, 2026

Historical Context

5 past events · Latest: Apr 16
5 events
  1. Apr 16

    Brand architecture update

    24h Move
    -1.9%

    Streamlined brands into three portfolios debuting at major scientific meetings.

  2. Apr 14

    Earnings call scheduled

    24h Move
    +2.0%

    Set date and access details for Q3 fiscal 2026 results call.

  3. Mar 25

    Product portfolio expansion

    24h Move
    +0.5%

    Expanded COMET spatial biology suite with new panels and amplification kits.

  4. Feb 24

    Investor conferences

    24h Move
    +5.2%

    Announced presentations at two early March 2026 healthcare investor conferences.

  5. Feb 16

    Regulatory milestone

    24h Move
    -2.4%

    Ella platform received CE-IVD marking enabling EU clinical deployment.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MINNEAPOLIS, May 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the Bank of America Securities 2026 Global Healthcare Conference on Tuesday, May 12, 2026, at 9:20 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio‑Techne Corporation (NASDAQ: TECH) is a global life sciences company headquartered in Minnesota, celebrating 50 years of empowering scientific and diagnostic communities to reach better answers. The company provides high‑quality reagents, analytical instruments, and precision diagnostics. Its portfolio is organized into three customer‑focused brands: R&D Systems™, Bio‑Techne Spatial™, and Bio‑Techne Diagnostics™, reflecting the scientific journey from discovery to translational research to clinical decision‑making. Bio‑Techne operates in 34 locations worldwide and employs approximately 3,100 people. In fiscal year 2025, the company generated over $1.2 billion in net sales. Its more than 500,000 products are used globally by academic researchers, biopharmaceutical and biotechnology companies, and clinical diagnostic laboratories.

For more information on Bio-Techne and its brands, please visit www.bio-techne.com or follow the company on social media at LinkedIn, X, or YouTube.

Contact:

David Clair, Vice President, Investor Relations


david.clair@bio-techne.com

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bank-of-america-securities-2026-global-healthcare-conference-302760526.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bio-Techne (TECH) present at the Bank of America Securities 2026 Global Healthcare Conference?

Bio-Techne will present on Tuesday, May 12, 2026 at 9:20 a.m. PDT. According to Bio-Techne, Kim Kelderman, President and CEO, will deliver the presentation and a live webcast will be provided through the company’s investor relations IR Calendar.

Who is presenting for Bio-Techne (TECH) at the May 12, 2026 conference?

Kim Kelderman, President and Chief Executive Officer, is presenting for Bio-Techne. According to Bio-Techne, Kelderman will lead the company’s presentation and management may address strategy and recent corporate developments during the webcast.

How can investors watch Bio-Techne's (TECH) webcast from the May 12, 2026 presentation?

Investors can watch a live webcast via the company’s investor relations IR Calendar page. According to Bio-Techne, the webcast link is available on the Bio-Techne investor relations website and will stream the presentation live at the scheduled time.

Will Bio-Techne (TECH) make presentation materials available from the May 12, 2026 event?

The company typically posts slides and replay on its investor relations site after conferences. According to Bio-Techne, presentation materials and an archived webcast are usually uploaded to the IR Calendar page following the live event.

What time is the Bio-Techne (TECH) presentation in Eastern Time on May 12, 2026?

The presentation is scheduled for 9:20 a.m. PDT, which is 12:20 p.m. EDT. According to Bio-Techne, viewers in Eastern Time should tune in at 12:20 p.m. EDT for the live webcast on the investor relations IR Calendar page.

Keep reading